已收盤 05-15 16:00:00 美东时间
-1.450
-3.26%
<span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Versant Media Group 2026年第一季度业绩会实录,以下是财务业绩回顾摘要: ## 1. 财务业绩 **总体收入表现:** - 总营收16.9亿美元,同比下降1%,主要受传统付费电视业务压力影响 - 调整后EBITDA为7.04亿美元,同比增长5%,利润率保持在30%以上 - 自由现金流5.58亿美元,受应收账款和应付账款时间性因素影响 - 季度末现金余额12亿美元,流动性充足 **分业务收入构成:** - 线性分销收入:10.1亿美元,同比下降7% - 广告收入:3.68亿美元,同比下降5% - 平台业务收入:1.92亿美元,
05-15 12:03
Versant Media Group, Inc. (NASDAQ: VSNT) shares are trading higher Thursday after it reported better-than-expected Q1 financial results.
05-14 21:08
On Thursday, Versant Media Group (NASDAQ:VSNT) discussed first-quarter financia...
05-14 20:44
Companies Reporting Before The Bell • Urban One (NASDAQ:UONEK) is expected to r...
05-14 19:11
Versant Media Group (NASDAQ:VSNT) reported quarterly earnings of $1.99 per share which beat the analyst consensus estimate of $1.63 by 22.09 percent. The company reported quarterly sales of $1.690 billion which beat the
05-14 19:02
今日重点评级关注:Needham:维持Artiva Biotherapeutics"买入"评级,目标价从18美元升至41美元;HC Wainwright & Co.:维持SAB Biotherapeutics"买入"评级,目标价从7美元升至10美元
05-13 11:46
JP Morgan analyst David Karnovsky initiates coverage on Versant Media Group (NASDAQ:VSNT) with a Neutral rating and announces Price Target of $43.
05-12 22:16
今日重点评级关注:Maxim Group:上调Theriva Biologics评级至"买入",目标价1美元;HC Wainwright & Co.:维持Bicara Therapeutics"买入"评级,目标价从40美元升至42美元
04-01 16:34
https://www.nytimes.com/2026/03/27/business/media/versant-vox-medias-podcasts.html
03-27 23:43
The BBC board has approved Matt Brittin’s appointment, according to reports, and he is expected to be named the corporation’s 18th director-general this week following final due diligence checks. Br...
03-24 13:15